VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
99%
- Product Code: 103234
CAS:
1383716-46-8
| Molecular Weight: | 391.47 g./mol | Molecular Formula: | C₂₁H₂₅N₇O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
VPS34 inhibitor 1, a PIK-III analogue, is primarily utilized in research settings to study the role of VPS34 in cellular processes. It is particularly valuable in investigating autophagy, a critical mechanism for cellular degradation and recycling. By inhibiting VPS34, this compound helps researchers understand how autophagy influences various physiological and pathological conditions, including cancer, neurodegenerative diseases, and immune responses. Additionally, it serves as a tool to explore the interplay between VPS34 and other signaling pathways, aiding in the development of targeted therapies for diseases where autophagy dysregulation plays a key role. Its application extends to drug discovery, where it is used to screen and validate potential therapeutic compounds targeting autophagy-related pathways.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $137.98 |
+
-
|
VPS34 inhibitor 1 (Compound 19, PIK-III analogue)
VPS34 inhibitor 1, a PIK-III analogue, is primarily utilized in research settings to study the role of VPS34 in cellular processes. It is particularly valuable in investigating autophagy, a critical mechanism for cellular degradation and recycling. By inhibiting VPS34, this compound helps researchers understand how autophagy influences various physiological and pathological conditions, including cancer, neurodegenerative diseases, and immune responses. Additionally, it serves as a tool to explore the interplay between VPS34 and other signaling pathways, aiding in the development of targeted therapies for diseases where autophagy dysregulation plays a key role. Its application extends to drug discovery, where it is used to screen and validate potential therapeutic compounds targeting autophagy-related pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :